32512069|t|Cu(II) disrupts autophagy-mediated lysosomal degradation of oligomeric Abeta in microglia via mTOR-TFEB pathway.
32512069|a|Copper dyshomeostasis is involved in the pathogenesis of Alzheimer's disease (AD). Microglia play a major role in the proteolytic clearance of oligomeric beta-amyloid (Abetao). Here, we investigated whether Cu(II) affects microglial Abetao clearance and whether this effect involves autophagy-lysosomal pathway. Microtubule associated protein 1 light chain 3 (LC3)-II and p62 protein levels and autophagic flux in Cu(II)-treated microglia were detected. Abetao clearance was detected by enzyme-linked immunosorbent assay (ELISA) and immunofluorescence. In vivo, Cu(II) and Abetao were injected into mouse hippocampus to evaluate Abeta clearance. The results showed that Cu(II) inhibited phagocytic uptake and intracellular degradation of Abetao in microglial cultures. Additionally, Cu(II) elevated LC3-II and p62 protein levels and impaired autophagic flux. It also inhibited transcription factor EB (TFEB) expression and lysosomal biogenesis. Moreover, Cu(II) activated mammalian target of rapamycin kinase (mTOR), an upstream signaling of TFEB. The mTOR inhibitor PP242 ameliorated Cu(II)-impaired TFEB expression, lysosomal biogenesis, autophagic flux, and Abetao clearance in microglia. In vivo, Cu(II) inhibited microglial Abetao clearance in mouse hippocampus, an effect accompanied with activation of mTOR and impairment of TFEB expression and lysosomal biogenesis. Collectively, our results suggest that Cu(II) reduces microglial Abetao clearance through disrupting lysosomal biogenesis and autophagic flux. This effect could involve modulation of mTOR-TFEB axis and was prevented by pharmacological antagonism of mTOR. This study reveals a novel mechanism for Cu(II) involvement in AD. Our results implicate that rescue of Cu(II)-impaired autophagy-mediated lysosomal degradation may provide a new strategy to benefit multiple neurodegenerative disorders.
32512069	0	6	Cu(II)	Chemical	-
32512069	71	76	Abeta	Gene	11820
32512069	94	98	mTOR	Gene	56717
32512069	99	103	TFEB	Gene	21425
32512069	113	119	Copper	Chemical	MESH:D003300
32512069	170	189	Alzheimer's disease	Disease	MESH:D000544
32512069	191	193	AD	Disease	MESH:D000544
32512069	281	287	Abetao	Gene	80908
32512069	320	326	Cu(II)	Chemical	-
32512069	346	352	Abetao	Gene	80908
32512069	473	476	LC3	Gene	66734
32512069	485	488	p62	Gene	18226
32512069	527	533	Cu(II)	Chemical	-
32512069	567	573	Abetao	Gene	80908
32512069	675	681	Cu(II)	Chemical	-
32512069	686	692	Abetao	Gene	80908
32512069	712	717	mouse	Species	10090
32512069	742	747	Abeta	Gene	11820
32512069	783	789	Cu(II)	Chemical	-
32512069	851	857	Abetao	Gene	80908
32512069	896	902	Cu(II)	Chemical	-
32512069	912	915	LC3	Gene	66734
32512069	923	926	p62	Gene	18226
32512069	990	1013	transcription factor EB	Gene	21425
32512069	1015	1019	TFEB	Gene	21425
32512069	1068	1074	Cu(II)	Chemical	-
32512069	1085	1121	mammalian target of rapamycin kinase	Gene	56717
32512069	1123	1127	mTOR	Gene	56717
32512069	1155	1159	TFEB	Gene	21425
32512069	1165	1169	mTOR	Gene	56717
32512069	1180	1185	PP242	Chemical	MESH:C572919
32512069	1198	1204	Cu(II)	Chemical	-
32512069	1214	1218	TFEB	Gene	21425
32512069	1274	1280	Abetao	Gene	80908
32512069	1314	1320	Cu(II)	Chemical	-
32512069	1342	1348	Abetao	Gene	80908
32512069	1362	1367	mouse	Species	10090
32512069	1422	1426	mTOR	Gene	56717
32512069	1445	1449	TFEB	Gene	21425
32512069	1526	1532	Cu(II)	Chemical	-
32512069	1552	1558	Abetao	Gene	80908
32512069	1670	1674	mTOR	Gene	56717
32512069	1675	1679	TFEB	Gene	21425
32512069	1736	1740	mTOR	Gene	56717
32512069	1783	1789	Cu(II)	Chemical	-
32512069	1805	1807	AD	Disease	MESH:D000544
32512069	1846	1852	Cu(II)	Chemical	-
32512069	1950	1977	neurodegenerative disorders	Disease	MESH:D019636
32512069	Association	56717	80908
32512069	Association	21425	56717
32512069	Negative_Correlation	MESH:C572919	56717
32512069	Association	MESH:D003300	MESH:D000544
32512069	Negative_Correlation	MESH:C572919	80908
32512069	Negative_Correlation	MESH:C572919	21425

